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Key findings Reference
A recent study has shown that CGA can effectively act against Al (III)-stimulated cytotoxicity in RAW264.7 cells through the mitogen-activated protein kinase (MAPK)/Akt-mediated caspase pathways.
Cheng et al., 2019
By suppressing the activation of pro-inflammatory and apoptotic signaling pathways, CGA may be very effective against inflammation and attenuating colitis severity. Vukelić et al., 2018 CGA, which might be used as a potential therapeutic compound for bovine mastitis, had anti-inflammatory activity by inhibiting nuclear factor kappa beta (NF-κB) activation. Gao et al., 2018 After treatment with CGA, liver injury and insulin resistance could be relieved by suppressing autophagy through the inactivation of the C-Jun N-terminal kinase pathway in a non-alcoholic fatty liver disease (NAFLD) rat model. Based on this finding, CGA could potentially be used for the treatment of NAFLD.
Yan et al., 2018
Crude extract of Aster koraiensis acted as a potent antiangiogenic agent. The antiangiogenic activity might be attributable to the bioactive component, CGA. Kim et al., 2018 CGA, when treated with Regorafenib, improved the anti-cytotoxicity action of Regorafenib in hepatocarcinoma (HCC) cells. This combined treatment as a drug might be a safe and more effective option in HCC therapy.
Refolo et al., 2018
Continuously taking CGA for a period of 6-months improved attention, executive, and memory functions in the elderly who complained of subjective memory loss. Kato et al., 2018 CGAs improve quality of coffee beverages by decreasing the concentration of 5-O-CGA, while maintain the aroma and taste profile. This might be useful to people with sensitive stomachs.
Siebert et al., 2018
CGA has a significant antidepressant response in sleep-deprived rats. The mechanism of action of CGA may involve the regulation of abnormal pathways, including metabolism of nicotinate and nicotinamide; metabolism of glyoxylate and dicarboxylate; metabolism of glycine, serine, and threonine; and metabolism of arginine and proline. Ma et al., 2018 CGA stimulates bacterial apoptosis in E. coli and the depletion of intracellular ROS (reactive oxygen species), which might regulate the progression of bacterial apoptosis-like death. Lee and Lee, 2018 Dietary supplementation with CGA enhances the growth performance and reduces the diarrhea incidences of the weaned pigs. It is suggested that CGA improved the antioxidant capacity and enhanced the intestinal digestion and absorption function.
Chen et al., 2018
Semen was effectively stored in 3.2 mg/mL of CGA at 15 °C for up to 24 hr. From this finding, it can be assumed that semen could be stored for longer durations if the CGA concentration increased (6.0 mg/ml or more).
Pereira et al., 2018
CGA, combined with phospholipid complex (PC), improved the post-myocardial infarction inflammatory response in aging hearts, making PC a promising candidate for the clinical development of CGA.
Li et al., 2018
CGA assuaged hepatotoxicity and cholestasis by reducing the uptake and synthesis of bilirubin and bile acids, and finally enhancing the metabolism and efflux of bilirubin and bile acids.
Zhu et al., 2018
By increasing cyclic adenosine monophosphate (cAMP) levels via adenylyl cyclase activation, CGA significantly reduced the carbachol-induced contractions of the mouse urinary bladder. Kaneda et al., 2018 CGA reduces human lens epithelial cells (hLECs) apoptosis and protects lenses from opacity induced by H2O2 via the BCL2 (B-cell lymphoma 2) associated X apoptosis regulator (Bax)/ BCL2 apoptosis regulator (Bcl-2) signaling pathway. CGA shows effective defenses against oxidative stress, which could treat a variety of diseases in clinical practice.
Song et al., 2018

Key findings Reference
CGA treatment could inhibit the retinal neoangiogenesis during diabetic retinopathy by nullifying high glucose (HG)-induced hypoxia-inducible factor 1-alpha (HIF-1α)-mediated paracrine vascular endothelial growth factor (VEGF) expression in microglia cells and reducing VEGF-induced angiogenesis in retinal endothelial cells. Mei et al., 2018 CGA is considered as a therapeutic agent for the treatment of diabetic nephropathy, showing antioxidant and anti-inflammatory effects that are activated via the modulation of the nuclear factor erythroid-derived 2-related factor 2 (Nrf2)/ heme oxygenase-1 (HO-1) and NF-ĸB pathways. Bao et al., 2018 CGA prevents acetaminophen (APAP)-induced hepatotoxicity through the Nrf2 antioxidative signaling pathway by blocking the binding of Nrf2 to its deterrence protein, Keap1. Extracellular regulated protein kinase (ERK) 1/2 play a vital role in regulating CGA-induced Nrf2 transcriptional activation. CGA could be utilized as a promising therapeutic agent for the detoxification of APAP-induced hepatotoxicity. Wei et al., 2018 CGA influences the expression of apoptosis genes related to the oxidative stress and p38 MAP-dependent pathways and the expression of genes encoding stem cell markers. CGA may show polyphenolic anti-cancer effects through the consumption of vegetables and fruits.
Yamagata et al., 2018
By reducing the apoptosis of neuronal cells, CGA mitigates the neuronal damage induced in alcohol exposed neonatal rat.
Guo and Li, 2017
CGA has the potential to relieve liver fibrosis through the miR-21-regulated TGF-β1/Smad7 signaling pathway, which suggests that CGA could act as a new anti-fibrosis agent against liver fibrosis.
Yang et al., 2017
By administering appropriate amounts of myricetin-3-O-β-rhamnoside and CGA synergistically, the fibroblastic and remodeling phases of wound repair are accelerated.
Moghadam et al., 2017
CGA controls several mechanisms of action for the development of highly valuable therapeutics for metabolic diseases, such as type 2 diabetes.
Sanchez et al., 2017 CGA shows antifungal activity against phytopathogenic fungi relevant to horticulture and agriculture, suggesting potential biofungicides activity in CGA-enriched wastes and by-products.
Martínez et al., 2017
CGA can modify the gut microbial community structure in the intestines, exhibiting lower intestinal and systemic inflammation, and also enhancing the course of the dextran sulfate sodium-induced colitis, which is linked to a proportional increase in Akkermansia.
Zhang et al., 2017
CGA has similar responses to caffeic acid. In vitro maturation (IVM) with 50 μM of CGA is particularly useful to the in vitro production (IVP) of porcine embryos; 50 μM of CGA prevents oocytes from DNA damage induced by oxidative stress. The addition of CGA to the maturation medium has the potential to enhance the porcine IVP system. Nguyen et al., 2017 CGA prevents the interleukin (IL)-1β-induced inflammatory response, through the NF-κB signaling pathway. CGA could be a suitable candidate for the treatment of osteoarthritis. Liu et al., 2017 CGA prevents focal cerebral ischemia reperfusion injury in a rat model by maintaining the inflammatory factor, hypoxia factor, and nerve growth factor. Miao et al., 2017 CGA prevents the progression of hepatocellular carcinoma via multiple pathways. CGA could be an effective chemopreventive agent for hepatocellular carcinoma. Yan et al., 2017 CGA retrained benign prostatic hyperplasia in model animals, and this mechanism could protect typeⅡ5-alpha reductase activity. Huang et al., 2017 Consumption of CGA for a period of 5 days significantly enhances fat oxidation during sleep, indicating that beverages containing CGA may be useful to lessen body fat and protect from obesity. Taking CGA also minimizes sleep latency without any adverse effects on sleep quality.
Park et al., 2017
Key findings Reference
CGA can be used as a neuraminidase blocker to prevent influenza A virus both in cellular and animal models, revealing a potential utility for the treatment of the influenza virus infection.
Ding et al., 2017
A self-microemulsifying drug delivery system (SMEDDS) promotes the oral bioavailability of CGA by enhancing its absorption and slowing the metabolism of absorbed CGA by changing its distribution from the liver to the kidney. SMEDDS is an increasingly utilized carrier for the oral delivery of CGA. Chen et al., 2017 CGA significantly protects mice from Con A-induced hepatitis by reducing the activation of Toll-like receptor (TLR) 4 signaling. This response lowers the expression of adhesion molecules and enhances the infiltration and activation of hepatic leukocytes and the production of pro-inflammatory cytokines. Yuan et al., 2017 CGA reduces glioma growth by enhancing M1-polarized macrophages and protecting M2 phenotypic macrophages as a potential therapeutic approach. Xue et al., 2017 CGA promotes potassium efflux, resulting in an apoptotic volume decrease (AVD) and G2/M cell cycle arrest in Candida albicans. Thus, potassium efflux via potassium channels improves CGA-induced apoptosis, stimulating several apoptotic processes.
Yun and Lee, 2017
CGA prevents Iso-induced vascular smooth muscle cells (VSMC) damage through the suppression of ROS generation. This finding suggests that CGA could be a novel treatment for vascular diseases.
Wang et al., 2016
CGA prevents both ɑ-naphthylisothiocyanate-induced intrahepatic cholestasis and liver injury. This protective mechanism is modulated through the down-regulation of signal transducer and activator of transcription 3 (STAT3) and NF-κB signaling. Tan et al., 2016 CGA mitigates the oxidative stress in streptozocin-induced diabetic nephropathy (DN) rats. Its molecular mechanism could prevent the endoplasmic reticulumstress response in DN. Ye et al., 2016 CGA is a novel therapeutic agent for preventing inflammatory hyperplasia of the synovium by enhancing synoviocyte apoptosis in patients with rheumatoid arthritis.
Lou et al., 2016
CGA significantly increases hepatic lipid dysregulation in rats by activating fatty acid metabolism enzymes, enhancing AMP-activated protein kinase activation, and modulating levels of hepatic fatty acids. Zhou et al., 2016 
